Related Experiment Video

Updated: Aug 30, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

LKB1 is the upstream kinase in the AMP-activated protein kinase cascade

Angela Woods1, Stephen R Johnstone, Kristina Dickerson

  • 1Cellular Stress Group, MRC Clinical Sciences Centre, Imperial College, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom.

Current Biology : CB
|November 15, 2003
PubMed

Insights

Mutations in the protein kinase LKB1 cause Peutz-Jeghers syndrome. This study identifies LKB1 as the major AMP-activated protein kinase kinase (AMPKK), linking it to energy homeostasis and metabolic diseases.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Human genetics

Background:

  • Inactivating mutations in the protein kinase LKB1 are linked to Peutz-Jeghers syndrome, a human cancer.
  • The precise role of LKB1 and its downstream targets remain largely undefined.
  • AMP-activated protein kinase (AMPK) is crucial for energy homeostasis and metabolic disease prevention.

Purpose of the Study:

  • To investigate if LKB1 is the primary AMP-activated protein kinase kinase (AMPKK) responsible for AMPK activation.
  • To establish a functional link between LKB1 and AMPK signaling pathways.

Main Methods:

  • Purification of AMPKK from rat liver.
  • Biochemical assays to assess LKB1's kinase activity.
  • Inhibition of LKB1 activity in cellular models to observe effects on AMPK activation.

Main Results:

  • AMPKK purified from rat liver was identified as LKB1.
  • Blocking LKB1 activity in cells abrogated AMPK activation under various stimuli.
  • LKB1 was previously shown to phosphorylate and activate AMPK in vitro.

Conclusions:

  • LKB1 is the major AMPKK, directly linking it to AMPK activation.
  • This finding connects LKB1 and AMPK pathways, previously considered distinct.
  • The identified link has implications for understanding diseases associated with both pathways, including cancer and metabolic disorders.

More Related Videos

Assaying the Kinase Activity of LRRK2 in vitro06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

Identification of Kinase-substrate Pairs Using High Throughput Screening11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...